Three-Statement Breakdown
REVENUE UP
Revenue rose 10% year over year to $12.2B, and carried a 20.5% net margin.
REVENUE
+10.3%
12,241
GROSS PROFIT
+10.1%
10,155
NET INCOME
-5.2%
2,511
EPS (DILUTED)
—
—
| Income statement | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|
| Revenue |
|
3,378 | 5,992 | 8,399 | 9,917 | 11,102 | 12,241 | +10.3% |
| Cost of revenue |
|
(876) | (1,156) | (1,499) | (1,703) | (1,878) | (2,086) | +11.1% |
| Gross profit |
|
2,502 | 4,836 | 6,900 | 8,214 | 9,224 | 10,155 | +10.1% |
| Research & development |
|
(2,753) | (1,425) | (1,502) | (1,722) | (2,056) | (2,354) | +14.5% |
| SG&A |
|
(1,135) | (836) | (950) | (2,025) | (1,185) | (1,342) | +13.2% |
| Operating income |
|
-3,590 | 429 | 1,802 | 1,518 | 2,553 | 2,544 | -0.4% |
| Interest expense |
NOT DISCLOSED
|
-172 | -438 | -24 | -83 | — | — | — |
| Income tax |
|
-97 | (52) | (96) | -2,690 | (683) | (626) | -8.3% |
| Net income |
|
-4,585 | -352 | 1,893 | 4,792 | 2,648 | 2,511 | -5.2% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
SELECTED · GROSS PROFIT · YoY BRIDGE
FROM9,224
REVENUE+1,139
COST OF REVENUE-208
TO10,155
No bridge for this line yet — select Gross profit to see its YoY walk.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-08-06 ↗